289 related articles for article (PubMed ID: 15996257)
1. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.
Froud T; Ricordi C; Baidal DA; Hafiz MM; Ponte G; Cure P; Pileggi A; Poggioli R; Ichii H; Khan A; Ferreira JV; Pugliese A; Esquenazi VV; Kenyon NS; Alejandro R
Am J Transplant; 2005 Aug; 5(8):2037-46. PubMed ID: 15996257
[TBL] [Abstract][Full Text] [Related]
2. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
[TBL] [Abstract][Full Text] [Related]
3. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
[TBL] [Abstract][Full Text] [Related]
4. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
[TBL] [Abstract][Full Text] [Related]
5. Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol.
Toso C; Baertschiger R; Morel P; Bosco D; Armanet M; Wojtusciszyn A; Badet L; Philippe J; Becker CD; Hadaya K; Majno P; Bühler L; Berney T;
Am J Transplant; 2006 May; 6(5 Pt 1):1049-58. PubMed ID: 16611343
[TBL] [Abstract][Full Text] [Related]
6. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.
O'Connell PJ; Hawthorne WJ; Holmes-Walker DJ; Nankivell BJ; Gunton JE; Patel AT; Walters SN; Pleass HC; Allen RD; Chapman JR
Med J Aust; 2006 Mar; 184(5):221-5. PubMed ID: 16515432
[TBL] [Abstract][Full Text] [Related]
7. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.
Froud T; Baidal DA; Faradji R; Cure P; Mineo D; Selvaggi G; Kenyon NS; Ricordi C; Alejandro R
Transplantation; 2008 Dec; 86(12):1695-701. PubMed ID: 19104407
[TBL] [Abstract][Full Text] [Related]
8. Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients.
Koh A; Imes S; Kin T; Dinyari P; Malcolm A; Toso C; Shapiro AM; Senior P
Transplantation; 2010 Feb; 89(3):361-5. PubMed ID: 20145529
[TBL] [Abstract][Full Text] [Related]
9. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation.
Turgeon NA; Avila JG; Cano JA; Hutchinson JJ; Badell IR; Page AJ; Adams AB; Sears MH; Bowen PH; Kirk AD; Pearson TC; Larsen CP
Am J Transplant; 2010 Sep; 10(9):2082-91. PubMed ID: 20883542
[TBL] [Abstract][Full Text] [Related]
10. Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations.
Berney T; Bucher P; Mathe Z; Andres A; Bosco D; Mage R; Toso C; Oberholzer J; Becker C; Philippe J; Bühler L; Morel P
Transplant Proc; 2004 May; 36(4):1121-2. PubMed ID: 15194390
[TBL] [Abstract][Full Text] [Related]
11. Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up.
Lehmann R; Weber M; Berthold P; Züllig R; Pfammatter T; Moritz W; Mädler K; Donath M; Ambühl P; Demartines N; Clavien And PA; Andreia Spinas G
Am J Transplant; 2004 Jul; 4(7):1117-23. PubMed ID: 15196070
[TBL] [Abstract][Full Text] [Related]
12. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.
Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH
Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445
[TBL] [Abstract][Full Text] [Related]
13. Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α.
Matsumoto S; Takita M; Chaussabel D; Noguchi H; Shimoda M; Sugimoto K; Itoh T; Chujo D; SoRelle J; Onaca N; Naziruddin B; Levy MF
Cell Transplant; 2011; 20(10):1641-7. PubMed ID: 21396171
[TBL] [Abstract][Full Text] [Related]
14. Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept.
Faradji RN; Tharavanij T; Messinger S; Froud T; Pileggi A; Monroy K; Mineo D; Baidal DA; Cure P; Ponte G; Mendez AJ; Selvaggi G; Ricordi C; Alejandro R
Transplantation; 2008 Dec; 86(12):1658-65. PubMed ID: 19104401
[TBL] [Abstract][Full Text] [Related]
15. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.
Hirshberg B; Mog S; Patterson N; Leconte J; Harlan DM
J Clin Endocrinol Metab; 2002 Dec; 87(12):5424-9. PubMed ID: 12466330
[TBL] [Abstract][Full Text] [Related]
16. Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression.
Nijhoff MF; Engelse MA; Dubbeld J; Braat AE; Ringers J; Roelen DL; van Erkel AR; Spijker HS; Bouwsma H; van der Boog PJ; de Fijter JW; Rabelink TJ; de Koning EJ
Am J Transplant; 2016 Jan; 16(1):246-53. PubMed ID: 26288226
[TBL] [Abstract][Full Text] [Related]
17. Islet transplantation for brittle type 1 diabetes: the UIC protocol.
Gangemi A; Salehi P; Hatipoglu B; Martellotto J; Barbaro B; Kuechle JB; Qi M; Wang Y; Pallan P; Owens C; Bui J; West D; Kaplan B; Benedetti E; Oberholzer J
Am J Transplant; 2008 Jun; 8(6):1250-61. PubMed ID: 18444920
[TBL] [Abstract][Full Text] [Related]
18. Multicenter Australian trial of islet transplantation: improving accessibility and outcomes.
O'Connell PJ; Holmes-Walker DJ; Goodman D; Hawthorne WJ; Loudovaris T; Gunton JE; Thomas HE; Grey ST; Drogemuller CJ; Ward GM; Torpy DJ; Coates PT; Kay TW;
Am J Transplant; 2013 Jul; 13(7):1850-8. PubMed ID: 23668890
[TBL] [Abstract][Full Text] [Related]
19. [Focus on Islets of Langerhans transplantation].
Bayle F
Presse Med; 2001 Sep; 30(24 Pt 2):19-20. PubMed ID: 11577579
[TBL] [Abstract][Full Text] [Related]
20. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.
Barshes NR; Lee T; Goodpasture S; Brunicardi FC; Alejandro R; Ricordi C; Soltes G; Barth M; Hamilton D; Goss JA
Transplant Proc; 2004 May; 36(4):1127-9. PubMed ID: 15194393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]